openPR Logo
Press release

Parkinson ’s Disease Therapeutics Market: Global Industry Analysis and Opportunity Assessment, 2018 – 2024

02-04-2019 11:42 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Infinium Global Research

/ PR Agency: Infinium Global Research
Parkinson ’s Disease Therapeutics Market

Parkinson ’s Disease Therapeutics Market

The report defines global Parkinson’s disease therapeutics market as the therapy used in the treatment of Parkinson's disease. Parkinson's disease is a long-term degenerative disorder of the nervous system that mainly affects the nerve cells in the brain.  Parkinson's has several symptoms including muscle stiffness, uncontrolled body movement, balance problems and improper motor movements. Presently Parkinson's disease is incurable. The treatment is only available to manage the symptoms of Parkinson’s.

Request a Discount on Standard Prices of this Premium Report @

Parkinson's is the second most common degenerative neurological disorder. According to the National Center for Biotechnology Information, PD affects 1% of the population above 60 years, each year. The growing prevalence of Parkinson's disease among the aged population drives the growth of Parkinson’s disease therapeutics market. In addition, rising geriatric population, growing environmental factors and genetic heredity are contributing to the growth of Parkinson’s disease therapeutics market.

Market Segmentation by Drug Class

Global Parkinson’s disease Therapeutics Market by Drug Class segmented as Carbidopa/Levodopa, Dopamine Receptor Agonists, Mao Inhibitors, Mao Inhibitors, Anticholinergics and Other Drugs. Among the drug class, Carbidopa/Levodopa medication is used to treat symptoms of Parkinson's disease. This medication changes into dopamine in the brain to control the movement. In addition, Dopamine Receptor Agonists has less potent than levodopa so they are beneficially used to treat symptoms for long periods of time. Newly developed therapeutics for the Parkinson's disease is getting approved by the Federal Drug Administration (FDA) that in turns to promote the growth of Parkinson’s disease therapeutics market.

Regional Analysis

Among the geographies, North America holds the maximum share in the Parkinson’s disease therapeutics market and expected to be the dominating region in this market over the forecast period. As per the Parkinson Association of the Carolinas, nearly 60,000 Americans are diagnosed with Parkinson’s disease each year. The growing prevalence of Parkinson’s disease in North America drives the growth of Parkinson’s disease therapeutics market in this region. In addition, Asia Pacific region is the fastest growing region in the Parkinson’s disease therapeutics market owing to the growth in geriatric population and developing healthcare infrastructure.

Competitive Landscape

The report provides profiles of the companies in the global Parkinson's disease therapeutics market such as GSK, Merck, Novartis, Teva, Boehringer Ingelheim, Impax, Abbvie, Valeant Pharmaceuticals, Lundbeck and Sun Pharma.

Read Detailed Index of full Research Study @

About Infinium Global Research

Infinium Global Research and Consulting Solutions is started with a single motto of being a business partner of the first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.

Contact Us:

Infinium Global Research
Office No. 04, 06, Ganadhish Empire,
Rahatani Corner, Pune, MH 411027

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parkinson ’s Disease Therapeutics Market: Global Industry Analysis and Opportunity Assessment, 2018 – 2024 here

News-ID: 1556568 • Views: 167

More Releases from Infinium Global Research

Amidst of COVID-19 Outbreak, Infinium Extends Its Support to the Industry by Off …
We understand that industries are affected worse than before. The global outbreak of Coronavirus has brought all of us to stand still and have negatively impacted the companies and industries financially and non-financially. Get Discount on Research Report@ What we assure the industries is that they must not panic about the situation as we believe that every cloud has a silver lining. We will surely bounce back and hit the
Genome Engineering Market: Global Industry Analysis, Trends, Market Size and For …
Our latest research report entitled Genome Engineering Market (by technology (clustered regularly interspaced short palindromic repeats, and other), application (cell line engineering, animal genetic engineering, and other) and end-user (biotechnology & pharmaceutical companies, academic & government research institutes and others)) provides complete and deep insights into the market dynamics and growth of Genome Engineering. Latest information on market risks, industry chain structure Genome Engineering cost structure and opportunities are offered
Computed Tomography Market 2018 : Global Industry Growth, Opportunities, Consump …
Our latest research report entitled Computed Tomography Market (by application (cardiovascular, oncology, diagnostics, neurology, and spinal application), types (low slice, medium slice, and high slice), end- user (diagnostic services, hospitals and clinics)) provides complete and deep insights into the market dynamics and growth of Computed Tomography. Latest information on market risks, industry chain structure Computed Tomography cost structure and opportunities are offered in this report. The past, present and forecast
Global Protein Ingredients Market – Invention Analysis, Size, Share, Evolution …
Our latest research report entitled Protein Ingredients Market (by source (animal source and plant source), application (food & beverage, cosmetics & personal care, infant formulations animal feed and pharmaceuticals)) provides complete and deep insights into the market dynamics and growth of Protein Ingredients. Latest information on market risks, industry chain structure Protein Ingredients cost structure and opportunities are offered in this report. The past, present and forecast market information will

All 5 Releases

More Releases for Parkinson

QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency. The firm recognised that to continue delivering high quality services to its clients it needed to provide
Wolff Parkinson White syndrome Market found Future opportunities of 2023
The Analysis presents the study of Global Wolff Parkinson White syndrome Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Global
Parkinson Research Foundation PRF Encourages Patients To Attend Upcoming Cruise …
PRF is hosting its fourth educational cruise from January 8 – 15, 2012. Cruisers will set sail out of Port Canaveral, Florida on Royal Caribbean’s Freedom of the Seas to embark on a seven-night Western Caribbean adventure. The Parkinson Research Foundation (PRF) developed an educational cruise program to help Parkinson patients, caregivers and their loved ones learn about Parkinson’s and connect with fellow patients from across the world. Each PRF
The Parkinson Research Foundation (PRF), a non-profit organization with a dedicated patient education program, will return to the Western Caribbean for its fourth educational cruise. PRF developed its educational cruise program to give Parkinson patients, caregivers family and loved ones unrivaled access to experts in the movement-disorder field. After visiting the Bahamas and Alaska on the first two respective PRF cruises, PRF’s ventured to the Western Caribbean on its most
PARKINSON RESEARCH FOUNDATION (PRF) Develops New Patient Outreach Program
One of the principal missions of the Parkinson Research Foundation (PRF) that distinguishes it from other Parkinson organizations is PRF’s focus on patient education; specifically education that enables Parkinson patients and their caregivers to live fuller and more comfortable lives with Parkinson's disease. The Foundation’s educational events, including educational cruises, gather leading Parkinson experts, therapists and nutritionists from across the country to offer life-changing tools and knowledge for individuals affected
Parkinson`s Disease:New Hope Educational Conference
PARKINSON’S DISEASE: NEW HOPE EDUCATIONAL CONFERENCE Become knowledgeable about the advancements in surgery The Parkinson Research Foundation is proud to announce that Dr. James Schumacher will be speaking about advances in surgery at our fourth annual New Hope for Parkinson’s conference on November 1st in Boca Raton. Dr. Schumacher is an internationally known expert in the field of neurosurgical treatment of Parkinson’s disease and movement disorders. He has an extensive background and